Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapy

Kwan Sik Lee, Kwan Soo Byun, Young Hwa Chung, Seung Woon Paik, Joon Yeol Han, Kwon Yoo, Hee Won Yoo, Byung Chul Yoo, Hyo Suk Lee

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Medicine and Dentistry